SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Serologicals Corp (SERO) -- Ignore unavailable to you. Want to Upgrade?

To: Ausdauer who wrote (19)9/8/1999 8:45:00 PM
From: Joe Wesley  Read Replies (1) | Respond to of 23
 
Hi Aus:

I traded this one when it fell in April.

I am not buying much until they get the $75 million credit line together.

The Pentex acquisition took a lot of their cash so the loss of the anti-D business couldn't have happened at a worse time. This news today adds to the problem.

AA



To: Ausdauer who wrote (19)9/8/1999 10:54:00 PM
From: PuddleGlum  Respond to of 23
 
Auddauer-
I just re-read an old Forbes article yesterday on SERO, which was positive. The stock is at $5, where it bottomed out last Spring, so there is hope that it will hold at this level. But if it drops just a quarter or 1/2 here then I'd say you'll see despair kick in and it'll sink even more. As Amateur stated, it's probably wise to wait until something positive develops before adding a position.

pg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News